Evidence map›Paper›PMID 22160468›Full record

ArticleMolecular biology reports2012

A novel mutation (Cys308Phe) of the LDL receptor gene in families from the South-Eastern part of Poland.

Małgorzata Waluś-Miarka, Marek Sanak, Barbara Idzior-Waluś, Przemysław Miarka, Przemysław Witek, Maciej T Małecki, Danuta Czarnecka

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Molecular biology reports, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Małgorzata Waluś-MiarkaDepartment of Metabolic Diseases, Jagiellonian University, Medical School, Kopernika 15, 31-501, Kraków, Poland. mmwalus@wp.pl
Marek Sanak
Barbara Idzior-Waluś
Przemysław Miarka
Przemysław Witek
Maciej T Małecki
Danuta Czarnecka
Jagiellonian University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this investigation was to characterize a new mutation in the LDL-receptor (LDLR) gene in three families with clinically diagnosed familial hypercholesterolemia (FH) from the South-Eastern part of Poland. Mutational screening with exon by exon sequencing analysis was performed in all probands. The novel mutation c986G>T (Cys308Phe) in the exon 7 of LDLR gene was found in three apparently unrelated probands with FH. Analysis of the receptor activity of peripheral blood lymphocytes by binding and uptake of DiL-LDL showed a significant reduction (by 24% versus healthy control) of the fluorescent label in the lymphocytes of patients heterozygous for this mutation. Concentrations of serum LDL-C in probands before treatment were between 9.5 and 10.5 mmol/l. All patients had corneal arcus and tendon xanthoma. Clinically, families were characterized by premature coronary artery disease. This mutation occurred relatively frequently in our group of patients with FH, but this could be explained by a founder effect since we demonstrated their common ancestors.

Indexed as

AdultAgedAmino Acid SequenceBase SequenceChromosome SegregationDNA Mutational AnalysisEndocytosisExonsFamilyFemaleHeterozygoteHumansMaleMiddle AgedMolecular Sequence DataMutationLDLR protein, humanReceptors, LDL

Identifiers

PMID22160468
PMCPMC3310989
OpenAlexW1970749007

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.